Integrated Biosciences
Redwood City
About Integrated Biosciences
Integrated Biosciences develops next-generation therapeutics for age-related diseases. Originating from labs at Harvard, MIT, and UCSB and with breakthrough publications in Nature and Science, Integrated Biosciences has demonstrated the first AI-driven discovery of anti-aging drug candidates, as well as the first novel structural class of antibiotics in 60 years.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $17.2M
- Funding stage: Seed
- Last round: Seed (Oct 2024)
- Website: integratedbiosciences.com
- Phone: [email protected]
Industries & Categories
Biopharma, Biotechnology, Life Science, Machine Learning, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/integrated-biosciences-59288 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.